PMGC Holdings (ELAB) Gross Margin (2022 - 2026)
PMGC Holdings (ELAB) posted Gross Margin of 33.79% for Q1 2026, down 4.2% sequentially from 35.28% in Q4 2025, and down 4617.0% YoY from 0.75% in Q1 2025.
PMGC Holdings (ELAB) Gross Margin (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Gross Margin for 5 years, with the latest figure at 33.79% in Q1 2026.
- Quarterly Gross Margin fell 4617.0% year-over-year to 33.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 32.69% (down 4079.0% YoY) and the FY2025 annual result came in at 31.4%, down 4143.0% from the prior year.
- Gross Margin retreated to 33.79% in Q1 2026 per ELAB's latest filing, from 35.28% in the prior quarter.
- Over five years, Gross Margin peaked at 79.96% in Q1 2025 and troughed at 27.29% in Q3 2025.
- A 5-year average of 60.45% and a median of 66.05% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2025: Gross Margin surged 1101 bps in 2023, then sank 4739 bps in 2025.
- Over 5 years, Gross Margin stood at 56.41% in 2022, then increased by 17 bps to 66.09% in 2023, then advanced by 9 bps to 72.01% in 2024, then sank by 51 bps to 35.28% in 2025, then fell by 4 bps to 33.79% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 33.79%, 35.28%, and 27.29% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | - |
| 10 | PMGC Holdings | 32.11 Mn | 13.31 Mn | 385,691.00 | 29.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.79% |
| Dec 31, 2025 | 35.28% |
| Sep 30, 2025 | 27.29% |
| Mar 31, 2025 | 79.96% |
| Dec 31, 2024 | 72.01% |
| Sep 30, 2024 | 74.68% |
| Jun 30, 2024 | 72.54% |
| Mar 31, 2024 | 72.52% |
| Dec 31, 2023 | 66.09% |
| Sep 30, 2023 | 66.01% |
| Jun 30, 2023 | 65.82% |
| Mar 31, 2023 | 68.89% |
| Dec 31, 2022 | 56.41% |
| Sep 30, 2022 | 55.01% |